Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and Inflammation

Clinical trial NCT07604038 · COMPLETED

Trial details

NCT number: NCT07604038
Sponsor: Kioga Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Stress Resilience Systemic Inflammation General Wellbeing Sleep Quality Safety

Start date: 2025-08-14
Primary completion: 2026-01-15
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.